Literature DB >> 21145

Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.

P Vareilles, D Silverstone, B Plazonnet, J C Le Douarec, M L Sears, C A Stone.   

Abstract

The effect of timolol, propranolol, epinephrine, and isoproterenol on intraocular pressure (IOP) (measured by tonometry) were compared after topical administration in conscious rabbits. Epinephrine and isoproterenol decreased IOP in normotensive rabbits, whereas propranolol had no effect. Timolol produced only a slight and inconsistent lowering of IOP in normotensive rabbits. All four agents reduced IOP elevated by an oral water load; the adrenergic agonists were substantially more active than the two beta-adrenergic blocking agents. In alpha-chymotrypsin-induced ocular hypertension, epinephrine, isoproterenol, and timolol were essentially equally effective, whereas propranolol exhibited only weak activity. In this latter model, timolol did not lose its effectiveness after multiple instillations (three/day) over an 8-day period. The concentration of timolol in the acqueous humor after topical application of effective hypotensive doses was relatively high as compared to that found in plasma. In addition, topical doses of timolol required to lower IOP were considerably greater than those needed to reduce or block the ocular hypotensive activity of isoproterenol. The mode of action and therapeutic implications of beta-adrenergic blocking agents in glaucoma are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21145

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

Review 1.  Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Authors:  D Ormrod; K McClellan
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

2.  L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.

Authors:  M F Sugrue; P Gautheron; P Mallorga; T E Nolan; S L Graham; H Schwam; K L Shepard; R L Smith
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Some aspects of waterloadings in rabbits.

Authors:  A C van Loenen; O P van Bijsterveld; F Nijkamp
Journal:  Doc Ophthalmol       Date:  1984-02-29       Impact factor: 2.379

4.  R-enantiomer of timolol: a potential selective ocular antihypertensive agent.

Authors:  N N Share; V J Lotti; P Gautheron; C Schmitt; D M Gross; R A Hall; C A Stone
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

5.  Beta adrenergic receptors in pigmented ciliary processes.

Authors:  G E Trope; B Clark
Journal:  Br J Ophthalmol       Date:  1982-12       Impact factor: 4.638

6.  [The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].

Authors:  M Ober; A Scharrer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

7.  How can the bioavailability of timolol be enhanced? A pharmacokinetic pilot study of novel hydrogels.

Authors:  N von der Ohe; M Stark; H Mayer; H Brewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

8.  Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.

Authors:  C Schmitt; V J Lotti; J C Le Douarec
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

9.  Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoichi Inoue
Journal:  Clin Ophthalmol       Date:  2010-10-21

10.  Concentration of timolol in aqueous humour.

Authors:  L J Blanksma
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.